Vimarsana
Biggest News Aggregation in the World

Series Session News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Series Session. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Series Session Today - Breaking & Trending Today

Deciphera Pharmaceuticals Announces Second Quarter 2023 Financial Results - Vimarsana News

Deciphera Pharmaceuticals Announces Second Quarter 2023 Financial Results

Published: August 9, 2023

– Second Quarter 2023 Total Revenue of $38.3 Million; Net Product Revenue for QINLOCK® (ripretinib) Increased 18% to $37.3 Million Compared to Second Quarter 2022 –– Top-line Results for MOTION Pivotal Phase 3 Study of Vimseltinib Expected in Fourth Quarter 2023 –– INSIGHT Pivotal Phase 3 Study of QINLOCK in Second-...

Source: pharmiweb.com
Related Topics:
New ZealandUnited StatesUnited KingdomHong KongDaniell FlynnDan FlynnJamesa BristolMaghan MeyersSteve HoerterDashyant DhanakDavid RosenPfizer IncDeciphera Pharmaceuticals IncResearch EngineExchange CommissionDeciphera PharmaceuticalsAmerican Association For CancerAmerican Society Of Clinical OncologyIncyte CorporationCompany FounderChairperson Or CoCanadian Pharmaceutical AllianceZai LabDrug AdministrationEuropean Union
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Q4 2022 Earnings Call Transcript - Vimarsana News

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Q4 2022 Earnings Call Transcript

Published: February 8, 2023

Operator: Good morning, everyone, and welcome to Deciphera Pharmaceuticals Fourth Quarter and Full Year 2022 Financial Results Conference Call. At this time all participants are in a listen-only mode.

Source: insidermonkey.com
Related Topics:
New ZealandMatt ShermanDaniel WolleTucker KellyMargarida DuarteDan MartinSteve HoerterJen LarsonHead Of InternationalZai LabChina National Healthcare Security AdministrationDeciphera Pharmaceuticals Fourth QuarterDeciphera Pharmaceuticals IncNational Reimbursement Drug ListDeciphera PharmaceuticalsCall Transcript FebruaryFull YearResults ConferenceSenior Vice PresidentChief Executive OfficerChief Commercial OfficerChief Medical OfficerChief FinancialPrivate Securities Litigation Reform ActSeries Session